These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16569525)

  • 21. Nesiritide in acute heart failure.
    Drazner M; McGuire DK; de Lemos JA
    Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
    [No Abstract]   [Full Text] [Related]  

  • 22. Nesiritide therapy for decompensated heart failure.
    Rempher KJ
    Clin Nurse Spec; 2002 May; 16(3):157-9. PubMed ID: 12021617
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 24. The challenges of properly identifying the cause of heart failure hospitalization.
    Ghali JK
    Arch Intern Med; 2010 Jul; 170(14):1274-5; author reply 1275. PubMed ID: 20660852
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of nesiritide to treat acute decompensated heart failure.
    Hachey DM; Smith T
    Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959
    [No Abstract]   [Full Text] [Related]  

  • 26. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL; Russell IA
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):780-7. PubMed ID: 15650995
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical review and recommendations for nesiritide use in the emergency department.
    Collins SP; Hinckley WR; Storrow AB
    J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 31. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptides in management of acute decompensated heart failure.
    Yancy CW
    Heart Fail Clin; 2006 Jul; 2(3):353-64. PubMed ID: 17386904
    [No Abstract]   [Full Text] [Related]  

  • 33. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
    Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction: optimizing heart failure management.
    Heywood JT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S1-2. PubMed ID: 15627914
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S; Clarke K; Srinivasan V; Gradman A
    QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does nesiritide reduce mortality and readmission in decompensated heart failure?
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(2):133-4. PubMed ID: 22569604
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
    Silver MA
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB; Fedson SE; Cronin DC
    Transplant Proc; 2007; 39(1):308-10. PubMed ID: 17275531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.